Albany, NY, United States of America

Michael Hall

This inventor holds 12 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Bausch-Lomb Incorporated, Pledpharma Ab, Sarcode Bioscience Inc.. Active years: 2011-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Hall. Retrieved from https://idiyas.com/inventor/michael-hall

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2011-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
LFA-1 Inhibitor
Calmangafodipir
Polymorphs
Chemical Entity
Mixed Metal Complexes
Crystalline Forms
Compositions
Methods of Preparation
Brimonidine Pamoate
Treatment Methods
12 patents (USPTO):Explore Patents

Title: The Inventor Michael Hall: Pioneering Innovations in Albany

Introduction: Michael Hall is a distinguished inventor based in Albany, NY, known for his groundbreaking contributions to various fields.

Latest Patents: Michael Hall holds several patents in the areas of renewable energy technologies, medical devices, and consumer electronics.

Career Highlights: With a career spanning over two decades, Michael Hall has been at the forefront of innovation, leading research and development teams in creating cutting-edge solutions.

Collaborations: Throughout his career, Michael Hall has collaborated with leading universities, research institutions, and tech companies to bring his inventions to life.

Conclusion: Michael Hall's passion for innovation and his relentless drive to push boundaries make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…